BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 26547334)

  • 1. [Low expression of SLC22A1 is associated with a poor prognosis of hepatocellular carcinoma: analysis of 303 patients].
    Wang ST; Shen SL; Hua YP; Chen B; Kuang M; Li SQ; He Q; Peng BG
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Oct; 35(10):1417-21. PubMed ID: 26547334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.
    Heise M; Lautem A; Knapstein J; Schattenberg JM; Hoppe-Lotichius M; Foltys D; Weiler N; Zimmermann A; Schad A; Gründemann D; Otto G; Galle PR; Schuchmann M; Zimmermann T
    BMC Cancer; 2012 Mar; 12():109. PubMed ID: 22439694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
    Li B; Shao Q; Ji D; Li F; Guo X; Chen G
    Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma.
    Peng SL; Yao DB; Zhao Y; Xu F; Jia CJ; Xu YQ; Dai CL
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):38-44. PubMed ID: 25635973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of carcinoembryonic antigen with prognosis of hepatocellular carcinoma after hepatectomy].
    Zhao J; Yan T; Bi X; Zhao H; Huang Z; Zhou J; Li Z; Li C; Cai J
    Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):430-4. PubMed ID: 25241784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
    Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
    Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
    Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
    Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma.
    Wu DH; Wang TT; Ruan DY; Li X; Chen ZH; Wen JY; Lin Q; Ma XK; Wu XY; Jia CC
    Biomed Pharmacother; 2018 Jan; 97():195-202. PubMed ID: 29091866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib.
    Herraez E; Lozano E; Macias RI; Vaquero J; Bujanda L; Banales JM; Marin JJ; Briz O
    Hepatology; 2013 Sep; 58(3):1065-73. PubMed ID: 23532667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
    Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
    Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
    Lautem A; Heise M; Gräsel A; Hoppe-Lotichius M; Weiler N; Foltys D; Knapstein J; Schattenberg JM; Schad A; Zimmermann A; Otto G; Lang H; Galle PR; Schuchmann M; Zimmermann T
    Int J Oncol; 2013 Apr; 42(4):1297-304. PubMed ID: 23440379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
    PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
    Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
    Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma.
    Tian F; Xu J; Xue F; Guan E; Xu X
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28546230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.